Strategic groups, networks and platforms
COVID-END : COVID-19 Evidence Network to support Decision-makers, McMaster University. Provides a list of databases with access to published systematic reviews and identifies ongoing reviews. Offers resources for researchers considering and conducting COVID-19 evidence syntheses.
CanCOVID : Networking platform to build collaboration, coordination, and open data sharing between all aspects of Canada's COVID-19 response, including researchers, clinical collaborators, funding agencies, government policy makers, and healthcare practitioners.
NCCMT : National collaborating centre for methods and tools, McMaster University. Provides a directory of completed and ongoing rapid evidence reviews on topics related to COVID-19. Provides tools, guides, resources and support to conduct rapid evidence reviews.
COVID-19 Ressources Canada : Collects canadian resources for researchers and clinicians, including databases of volunteers and reagents accessible online. Presents a list of research programs funded by canadien agencies. Provides a non-comprehensive list of international, national, provincial and local COVID-19 funding opportunities.
COVID-19 Research Project Tracker by UKCDR et GloPID-R : Tracks research projects funded by GLOPID-R member nations (UK, Canada, France, Japan, Australia, and others), and maps these against WHO priorities, in order to identify unmet needs in research and reduce duplication.
COVID-19 Innovation Hub by Global innovation Exchange : Collates and maps international innovations related to COVID-19 and provides a directory of start-ups and industry partners.
Crowdhelix network : Offers a free online “Open Innovation platform” to promote collaboration between international researchers in developing research and development proposals on COVID-19.
Coronavirus Innovation Map by StartupBlink : International map to locate innovations related to COVID-19 and aims to create links between researchers, industry partners and decision-makers.
COVID Collaborator by ZymeWorks : Aggregates leaders in drug development offering expert, discounted, and pro-bono services to accelerate treatments and vaccines developpement.